Home > Income Statement > BIOCON

BIOCON
Revenue

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹16,927 Cr₹15,262 Cr₹14,756 Cr₹11,174 Cr₹8,184 Cr

What is the latest Revenue of BIOCON ?

The latest Revenue ratio of BIOCON is ₹16,927 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹16,927 Cr
Mar2025₹15,262 Cr
Mar2024₹14,756 Cr
Mar2023₹11,174 Cr
Mar2022₹8,184 Cr

How is Revenue of BIOCON Trending?

Years Revenue % Change
Mar2026 ₹16,927 Cr
10.91
Mar2025 ₹15,262 Cr
3.43
Mar2024 ₹14,756 Cr
32.05
Mar2023 ₹11,174 Cr
36.54
Mar2022 ₹8,184 Cr -

Compare Revenue of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹67,159.9 Cr -0.7% -5.9% 15% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.7%

-5.9%

15%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses